Nifty 50
- Maruti Suzuki₹13,390758.00 (6.00%)
- Infosys₹1,077.20-31.60 (-2.85%)
- Mahindra & Mahindra₹3,497.90138.80 (4.13%)
- Tech Mahindra₹1,710.60-39.40 (-2.25%)
- Tata Motors PV₹262.9010.35 (4.10%)
- HCL Technologies₹1,319.80-24.90 (-1.85%)
- Eicher Motors₹7,983283.00 (3.68%)
- TCS₹2,344.90-34.60 (-1.45%)
- Bajaj Auto₹10,751181.00 (1.71%)
- Apollo Hospitals₹8,706.50-114.50 (-1.30%)
- Hindustan Unilever₹2,024.6031.60 (1.59%)
- Eternal₹362.20-3.80 (-1.04%)
- InterGlobe Aviation₹5,58585.70 (1.56%)
- Dr. Reddy's Labs₹1,385-13.20 (-0.94%)
- Bharat Electronics₹401.305.50 (1.39%)
- Shriram Finance₹965.20-4.80 (-0.49%)
- Grasim Industries₹3,103.1041.10 (1.34%)
- ICICI Bank₹1,593.70-7.60 (-0.47%)
- Nestle₹1,297.6016.00 (1.25%)
- Tata Consumer ₹1,125.90-5.00 (-0.44%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Indegene Becomes First Industry Partner of Indo-UK Life Science Corridor; Shares Fall 0.76%
Authored By HDFC SKY | Published at: Nov 19, 2026 11:21 AM IST
Indegene Limited has become the first industry partner of the Indo-UK Life Science Corridor, an initiative led by C-CAMP and Imperial Global India. The partnership aims to strengthen research collaboration, healthcare innovation and technology development between India and the United Kingdom. Indegene shares declined approximately 0.8% during morning trading on November 19, 2026.

Open Free Demat Account
Mumbai, November 19: Indegene Limited has become the first industry partner of the Indo-UK Life Science Corridor, an initiative led by C-CAMP and Imperial Global India. The partnership aims to support healthcare research, digital health and technology development between India and the UK. Meanwhile, Indegene shares fell around 0.76% to ₹650 during Thursday’s morning trading session.
Indegene Joins C-CAMP and Imperial College London’s Indo-UK Life Science Corridor
According to the company’s November 19 press release, Indegene has joined the Indo-UK Life Science Corridor as its first industry partner. The initiative is supported through the Imperial Global India programme and seeks to strengthen research collaboration and innovation between India and the United Kingdom. The corridor will connect research institutions, startups and industry participants to support the development and commercialisation of life sciences technologies. As an industry partner, Indegene will contribute its expertise in AI-enabled platforms, life sciences operations and digital healthcare solutions. The collaboration will focus on advancing innovation across several healthcare segments, including digital diagnostics, digital health, ageing-related care, brain science and mental health. The initiative also aims to help startups and research organisations access industry knowledge, technology resources and commercial opportunities. Indegene said the partnership would allow it to support the translation of scientific research into practical healthcare solutions and expand collaboration between the two countries. The company will work alongside C-CAMP and Imperial Global India to connect emerging technologies with healthcare industry requirements. The agreement represents a research and innovation partnership. The press release does not disclose any contract value, investment amount or direct revenue contribution from the collaboration.
Stock Market Snapshot
Indegene share price were trading at approximately ₹650 on Thursday, November 19, 2026, down ₹4.95 or 0.76% compared with the previous NSE closing price of ₹654.95 on November 18. The stock initially moved above ₹658 during morning trading and briefly approached ₹660 around 9:45 AM. However, the gains were short-lived. Selling pressure emerged after 10:00 AM, pushing the share price below ₹655. The stock subsequently declined towards ₹645 before recovering slightly to trade around ₹650. The supplied chart extends to approximately 10:55 AM IST. The quoted price and percentage movement are approximate because an exact last-traded price and timestamp are not displayed. No independently verified evidence directly links the stock’s decline to the Indo-UK Life Science Corridor announcement.

About Indegene Limited
Indegene Limited is a Bengaluru-headquartered technology company providing digital-first commercial, medical and regulatory solutions to the global life sciences industry. The company works with pharmaceutical, biotechnology and healthcare organisations, offering services involving artificial intelligence, digital transformation, medical affairs and commercial operations. Indegene combines healthcare industry expertise with technology platforms to support drug development, commercialisation and customer engagement.
Conclusion
Indegene’s participation as the first industry partner of the Indo-UK Life Science Corridor expands its involvement in international healthcare research and innovation. The collaboration with C-CAMP and Imperial Global India is expected to support technology development, startup engagement and scientific research partnerships between India and the United Kingdom. Indegene shares declined nearly 0.8% during morning trading on November 19, although the announcement’s direct impact on the stock movement remains unconfirmed.
Source:
- https://www.nseindia.in/get-quote/equity/INDGN/Indegene-Limited
Disclaimer
The information shared here is intended solely for informational and educational purposes and does not constitute investment recommendations. While we practice strict due diligence in curating daily market data, readers must perform independent research before trading. To flag any real-time data discrepancies or content concerns, please write to us at content@hdfcsec.com.
Open Free Demat Account
₹646.90
By signing up I certify terms, conditions & privacy policy

Join Us
Add as preferred source on Google










